An animal health company in South Dakota is taking a different approach to speed up the development of a Highly Pathogenic Avian Influenza vaccine.
HPAI continues to affect commercial and backyard flocks across the United States. As of late April, USDA says more than 58.7 million birds have been affected by the virus.
Medgene’s Chief Technology Officer Alan Young says the company has developed a two-dose vaccine to address different strains of avian influenza using USDA approved platform-based technology for hogs and cattle.
Be the first to comment